Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.22.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Changes in Fair Value of Level 3 Valued Instruments

The following tables present changes in fair value of level 3 valued instruments as of and for the three months ended March 31, 2022 and 2021:

 

    vivoPharm Business  
Balance – January 1, 2022   $ 11,000  
Additions     -  
Measurement adjustments     (4,500 )
Settlement     -  
Balance – March 31, 2022   $ 6,500  

 

    2020 Convertible Note     Warrant     Embedded Derivative  
Balance – January 1, 2021   $ -     $ -     $ 1,690  
Additions     3,746       635       325  
Measurement adjustments     4       (214 )     250  
Settlement     (3,750 )     (421 )     (2,265 )
Balance – March 31, 2021   $ -     $ -     $ -